EU Outsources Key Tobacco Control Responsibilities to Third Parties

Feb.27.2023
EU Outsources Key Tobacco Control Responsibilities to Third Parties
The EU outsources tobacco control responsibilities to non-elected bodies, causing concerns over accountability and potential conflicts of interest.

The European Tobacco Harm Reduction Advocates (ETHRA) has stated that the EU has outsourced key responsibilities for tobacco control to unelected organizations. ETHRA coordinates the actions of consumer groups and advocacy organizations throughout Europe. The organization warns that this has raised concerns about accountability and potential conflicts of interest.


EU officials had issued a tender notice for the "Support Action for the Tobacco Control Sector Single Framework Contract" earlier. Recently, they announced that the process has been completed and three contractors have been appointed.


The Spanish research and consultancy firm, Open Evidence, ...


The European Network for Smoking Prevention (ENSP)


Crete University


ETHRA has released a publicly available report which states that as part of their contribution, they will lead an "international consortium". This consortium will include the UK's ICF consultancy company, Brussels-based Milieu legal and policy consultancy, and Vital Strategies funded by Michael Bloomberg.


According to the Consumer Association, the contract will last for four years and is worth 3 million euros (approximately 22.03 million yuan).


According to the statement from ETHRA, the contractor's job will include:


Gather scientific literature, research, or clinical evaluations related to one or more tobacco or nicotine themes.


2. Statistical, market, and measurement analyses related to one or more tobacco or nicotine themes.


Tobacco Control Policy Model,


Behavioral research and analysis of specific issues.


Support for comprehensive health warnings,


Support for tobacco and related product labelling and packaging.


7. Restrictions on ingredients and related content/emission standards.


Support technological investment in information system development.


Conduct a legal assessment for the tobacco control measures of the European Union, countries, and international organizations.


The European Tobacco Harm Reduction Advocates (ETHRA) stated that the introductory notes in the tender specifications of the European Health and Digital Executive Agency (HaDEA) provide the legislative background of the EU's tobacco control policies, with the goal of achieving a "smoke-free tobacco generation" by 2040.


To achieve this goal, the plan is to revise the Tobacco Products Directive, which includes measures such as "implementing plain packaging and banning flavors in a completely transparent manner, improving the evaluation of ingredients through existing EU institutions, expanding taxes to new tobacco products, and addressing tobacco advertising, promotion, and sponsorship on the internet and social media.


According to the author of the document, there are concerns about the regulatory framework of the European Union. Currently, there is no systematic approach to dealing with all new tobacco and emerging products, and there is also a lack of flexibility to address rapidly developing products.


Advocates for reducing the harm of tobacco in Europe say, "This appears to be a daunting task for contractors. More importantly, it signifies that the policy-making responsibilities of the European Commission are now being outsourced to third parties. Accountability issues arise as well: when EU member states receive proposals to amend existing legislation, how do they know which proposals come from responsible officials and what role external actors played in shaping EU legislation?


Another issue is the potential conflict of interest with the winning bidder group. Of course, when it comes to the tobacco industry, they have a responsibility to declare that they have no conflict of interest in the tobacco industry. However, their work may have potential conflicts with other industries, such as the pharmaceutical industry that we may not be aware of.


References:


Efforts to Lobby on Behalf of Tobacco Industry The European Union (EU) has been found to be subcontracting its efforts to control tobacco, potentially undermining efforts to combat smoking. Investigations have discovered that the EU is employing companies which have links to the tobacco industry, leading to allegations of lobbying on behalf of the sector. The subcontractors are tasked with implementing tobacco control policies to be carried out across EU member states. Critics have voiced concern that this conflict of interest could threaten progress in reducing rates of smoking across Europe.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23